Cargando…
The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil
BACKGROUND: Brazilian patients have legal right to access unlicensed medicines undergoing clinical research, if there is evidence of efficacy and safety. This study investigated the occurrence of serious adverse events related to very high-cost medicines from clinical studies, expanded access and co...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248274/ https://www.ncbi.nlm.nih.gov/pubmed/32508660 http://dx.doi.org/10.3389/fphar.2020.00752 |